Phase II Study of TKI258 in Advanced Urothelial Carcinoma

Novartis Investigative Site, Vienna

Novartis Investigative Site, Taipei

Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering (2), New York

Novartis Investigative Site, Berlin

Duke University Medical Center Dept.ofDukeUniversityMedCtr(2), Durham

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

The West Clinic, Memphis

Novartis Investigative Site, Seville

University Chicago Hospital CTKI258A2201, Chicago

Novartis Investigative Site, Ulm

Nevada Cancer Institute Nevada Cancer Institute, Las Vegas

USC/Kenneth Norris Comprehensive Cancer Center Regulatory Contact 3, Los Angeles

University of California San Diego - Moores Cancer Center UCSD, La Jolla

Dana Farber Cancer Institute Dana 1230, Boston

Novartis Investigative Site, Victoria

Novartis Investigative Site, Toronto

Novartis Investigative Site, Dresden

Novartis Investigative Site, Roma

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Tainan City

Novartis Investigative Site, Leeds

Novartis Investigative Site, Southampton